Minimed Inc | TalkMarkets

Latest Posts

Clinical-Stage BioTech Drug Stocks Jumped 10% Last Week; UP 13% MTD

Article By: Lorimer Wilson

Sunday, July 14, 2024 11:17 AM EDT

The 10 clinical-stage AI-focused and psychedelic compound-based drug discovery companies in our Clinical-Stage BioTech Drug Stocks Portfolio are UP 12.8% MTD after having gone DOWN 13.2%, on average, in June and are now UP 13.8%, on average, YTD.

In this article: ATAI, RLAY, ABSI, ABCL, SDGR, MNMD, CMPS, GHRS, RXRX, EXAI

Read

Largest Clinical-Stage Biotech Drug Stocks Declined 6%

Article By: Lorimer Wilson

Saturday, June 22, 2024 6:16 PM EDT

Of the 10 clinical-stage AI-focused and psychedelic compound-based small cap drug discovery companies in this portfolio, only 1 advanced this week. On average they were down 6% last week and -21.6% YTD.

In this article: EXAI, ATAI, SDGR, MNMD, CMPS, ABCL, RLAY, GHRS, ABSI, RXRX

Read

Largest Psychedelic Compound Based Drug Stocks Fell 13% Last Week - Here's Why

Article By: Lorimer Wilson

Sunday, June 9, 2024 5:44 PM EDT

Stocks for companies developing psychedelic treatments fell last Wednesday after advisers to the Food and Drug Administration voted against a mental-health therapy using the drug MDMA.

In this article: ATAI, MNMD, CMPS, GHRS

Read

Clinical-Stage BioTech Drug Stocks Portfolio Jumped 7% In First Week Of May

Article By: Lorimer Wilson

Sunday, May 5, 2024 12:02 AM EDT

We look at the performance of 10 clinical-stage AI-powered and psychedelic compound-based small cap drug discovery companies during the first week of May and YTD.